13F HOLDINGS REPORT
Cormorant Asset Management, LP
Quarter ended Q3 2025 · Filed November 14, 2025 · Accession 0001583977-25-000011
Total Value
$1.45B
Positions
36
Other Managers
1
Confidential Omitted
No
Holdings (36)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | BRIDGEBIO ONCOLOGY THERAPEUT | BBOT | 17,878,594 | $207.0M | 14.29% |
| 2 | ABIVAX SA | AAVXF | 1,950,000 | $165.6M | 11.42% |
| 3 | EYEPOINT PHARMACEUTICALS INC | EYPT | 8,325,000 | $118.5M | 8.18% |
| 4 | RAPPORT THERAPEUTICS INC | RAPP | 3,192,521 | $94.8M | 6.54% |
| 5 | BRIDGEBIO PHARMA INC | BBIO | 1,400,000 | $72.7M | 5.02% |
| 6 | EDGEWISE THERAPEUTICS INC | EWTX | 4,010,000 | $65.0M | 4.49% |
| 7 | BRIGHT MINDS BIOSCIENCES INC | DRUG | 1,059,331 | $64.3M | 4.43% |
| 8 | ARCELLX INC | ACLX | 775,000 | $63.6M | 4.39% |
| 9 | INSMED INC | INSM | 430,000 | $61.9M | 4.27% |
| 10 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 2,175,000 | $61.9M | 4.27% |
| 11 | PRAXIS PRECISION MEDICINES I | PRAX | 1,000,000 | $53.0M | 3.66% |
| 12 | CENTESSA PHARMACEUTICALS PLC | CNTA | 1,925,000 | $46.7M | 3.22% |
| 13 | PHARVARIS N V | PHVS | 1,363,200 | $34.0M | 2.35% |
| 14 | CORBUS PHARMACEUTICALS HLDGS | CRBP | 2,375,000 | $30.0M | 2.07% |
| 15 | GH RESEARCH PLC | GHRS | 1,916,439 | $27.4M | 1.89% |
| 16 | CG ONCOLOGY INC | CGON | 625,000 | $25.2M | 1.74% |
| 17 | KORRO BIO INC | KRRO | 465,000 | $22.3M | 1.54% |
| 18 | MBX BIOSCIENCES INC | MBX | 1,225,000 | $21.4M | 1.48% |
| 19 | METSERA INC | 59267L107 | 400,000 | $20.9M | 1.44% |
| 20 | JANUX THERAPEUTICS INC | JANX | 850,000 | $20.8M | 1.43% |
| 21 | TARSUS PHARMACEUTICALS INC | TARS | 300,000 | $17.8M | 1.23% |
| 22 | CRINETICS PHARMACEUTICALS IN | CRNX | 400,000 | $16.7M | 1.15% |
| 23 | ENGENE HOLDINGS INC | ENGNW | 2,323,595 | $15.9M | 1.10% |
| 24 | ARCUTIS BIOTHERAPEUTICS INC | ARQT | 775,000 | $14.6M | 1.01% |
| 25 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 1,994,173 | $14.3M | 0.99% |
| 26 | AVIDITY BIOSCIENCES INC | 05370A108 | 300,000 | $13.1M | 0.90% |
| 27 | BIOAGE LABS INC | BIOA | 2,140,605 | $12.6M | 0.87% |
| 28 | AXSOME THERAPEUTICS INC | AXSM | 100,000 | $12.1M | 0.84% |
| 29 | CABALETTA BIO INC | CABA | 5,000,000 | $11.7M | 0.81% |
| 30 | ORUKA THERAPEUTICS INC | ORKA | 533,340 | $10.3M | 0.71% |
| 31 | ALUMIS INC | ALMS | 2,147,396 | $8.6M | 0.59% |
| 32 | BIOMEA FUSION INC | BMEA | 3,570,872 | $7.2M | 0.50% |
| 33 | AMYLYX PHARMACEUTICALS INC | AMLX | 500,000 | $6.8M | 0.47% |
| 34 | VAXCYTE INC | PCVX | 175,000 | $6.3M | 0.43% |
| 35 | ENLIVEN THERAPEUTICS INC | ELVN | 200,000 | $4.1M | 0.28% |
| 36 | BIOHAVEN LTD | BHVN | 10,000 | $150,100 | 0.01% |